Inside Merck’s $1 Billion Google Cloud Deal to Fast-Track AI Development
In Focus
- The Google Cloud-Merck partnership will run for multiple years
- The drugmaker plans to deploy AI across all functions
- Merck’s investment caters to the Gemini Enterprise license and AI infrastructure
U.S. drug manufacturer Merck & Co is partnering with Google Cloud to build its AI capabilities. Under a new deal revealed by Google Cloud during the Next conference, Merck plans to pay the tech giant up to $1 billion over multiple years. The Merck-Google AI deal builds on an existing partnership between the two companies.
“Merck’s collaboration with Google Cloud represents the next phase of our AI journey, extending our longstanding use of advanced technologies into an intelligent agentic ecosystem that will work alongside our teams as we enter one of the most significant launch periods in our company’s history,” Merck’s Chief Information and Digital Officer, Dave Williams noted in a statement posted on the company website.
What the Merck-Google Cloud Deal Entails
Merck’s AI investment will cater to AI infrastructure development, access to Google Cloud engineers, and a Gemini Enterprise license. Google launched Gemini Enterprise in October 2025 with the aim of bringing AI to every workflow. The AI partnership combines Merck’s leadership in scientific data with Google Cloud’s AI and cloud platforms.
The goal is to digitize Merck’s data and enhance the productivity of its 75,000 global workforce to accelerate its mission of saving lives. Executives from the two companies said that under the new Merck AI partnership, Google Cloud engineers will work alongside teams from the drug manufacturer.
“We’ve always said we wanted AI to play a positive role in society. One of the ways is to help people find cures to illnesses. They have the domain knowledge. We’re bringing the AI tools and platform and cyber capability to help them build using these tools,” Google Cloud CEO Thomas Kurian noted, as cited by Reuters.
No Specific Timelines Yet
The two companies did not specify the timelines for their collaboration. However, William expects the partnership to run for at least a decade. The companies added that their collaboration will involve deploying AI across Merck’s regulatory, research, production, and commercial functions to fast-track drug development.
Merck is planning to apply AI and cloud computing in its drug development process. The company plans to use the technology in computerized simulations of lab experiments. Merck will also use the technology to fast-track the regulatory.
“We feel there’s a tremendous opportunity there, and it’s a huge information challenge. This isn’t a pilot. We’re submitting dossiers in markets using this new capability, and we’re now scaling it globally,” Williams added.
What the Google Cloud Partnership Means for Merck
Previously, Merck has used AI to prepare sections of its clinical study reports. Merck has also used Google’s AI technology to reduce the time and cost of compiling the dossiers needed in different countries in order to process reimbursement for new drugs. By partnering with Google Cloud, Merck is looking to scale this approach across its operations.
